Table 3.
Factor | β | SE | Wals | P value | OR value | 95% CI | |
---|---|---|---|---|---|---|---|
| |||||||
Lower limit | Upper limit | ||||||
Age | 0.993 | 0.580 | 2.936 | 0.087 | 2.700 | 0.867 | 8.407 |
Diabetes mellitus | 0.029 | 0.615 | 0.002 | 0.963 | 1.029 | 0.308 | 3.437 |
TNM staging | 2.210 | 0.671 | 10.853 | 0.001 | 9.117 | 2.448 | 33.953 |
Chemotherapy regimen | 1.364 | 0.590 | 5.357 | 0.021 | 3.913 | 1.232 | 12.427 |
Chemotherapy cycle | 1.587 | 0.613 | 6.694 | 0.010 | 4.888 | 1.469 | 16.262 |
Post-chemotherapy albumin | 0.766 | 0.598 | 1.641 | 0.200 | 2.150 | 0.666 | 6.938 |
Pre-chemotherapy KPS | 0.573 | 0.591 | 0.938 | 0.333 | 1.773 | 0.556 | 5.651 |
Operation time | -0.210 | 0.681 | 0.095 | 0.758 | 0.810 | 0.213 | 3.080 |
Risk score | 3.997 | 0.681 | 34.431 | <0.001 | 54.434 | 14.324 | 206.866 |
Note: TNM: Tumor Node Metastasis.